![Clinton Musil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clinton Musil
Finansdirektör/CFO på
Skyhawk Therapeutics, Inc.
Profil
Clinton Musil currently works at Skyhawk Therapeutics, Inc., as President & Chief Financial Officer.
Mr. Musil also formerly worked at Wells Fargo & Co., as Vice President-Healthcare Investment Banking Group from 2013 to 2014, Deutsche Bank AG, as Vice President-Healthcare Investment Banking Group from 2014 to 2017, Personalis, Inc., as Chief Business Officer, Needham & Co. LLC, as Principal, Essex Woodlands Management, Inc., as Vice President, ARMO BioSciences, Inc., as Vice President-Corporate Development from 2017 to 2018, Catalyst Biosciences, Inc., as Chief Financial Officer from 2020 to 2021, and Skyhawk Therapeutics, Inc., as Chief Financial Officer from 2021 to 2024.
Mr. Musil received his undergraduate degree from the University of Arizona and Masters Business Admin degree from Harvard Business School.
Aktiva positioner av Clinton Musil
| Företag | Position | Start |
|---|---|---|
Skyhawk Therapeutics, Inc.
 Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Finansdirektör/CFO | 2024-11-30 |
Tidigare kända positioner av Clinton Musil
| Företag | Position | Slut |
|---|---|---|
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Finansdirektör/CFO | 2024-02-01 |
| CATALYST BIOSCIENCES | Finansdirektör/CFO | 2021-10-29 |
| ARMO BIOSCIENCES INC | Företagsledare/Principal | 2018-07-01 |
| DEUTSCHE BANK AG | Företagsledare/Principal | 2017-03-01 |
| WELLS FARGO & COMPANY | Företagsledare/Principal | 2014-07-01 |
Clinton Musils utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
85
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Wells Fargo & Co.
 Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services | Finance |
Deutsche Bank AG
 Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
Personalis, Inc.
 Personalis, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer genomics company which transforms the development of next-generation therapies | Health Services |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Health Technology |
